Researchers looked at a cancer therapy drug and found biosimilars bring competition to the market, with prices declining by more than half for some versions.
Researchers propose three strategies for mitigating negative impacts of the Inflation Reduction Act to ensure greater patient access, increased innovation and lower costs.
Erin Trish testified about pharmacy benefit managers before the Committee on Commerce, Science and Transportation.
The USC team’s study showed that an informational letter from the county medical examiner reduced the number of opioid prescriptions clinicians wrote.
Health experts see abortion as a public health issue — but in politics, it’s a campaign issue and this is a critical election year.
Growing evidence suggests that U.S. consumers overpay for generics by as much as 20% while pharmacy benefit managers pad profits, a USC Schaeffer Center white paper finds.
A USC expert on medicine access, drug utilization and pharmaceutical policy weighs in on what’s at stake across the country.
USC Schaeffer Center Senior Fellow Rosalie Liccardo Pacula warns of potential impact to public health.
USC Schaeffer study tracks down the insulin pricing and distribution chain.
Ginsburg, a senior fellow at the USC Schaeffer Center and professor of practice at USC Price, was recognized for his role in shaping and influencing health policy.
